EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Osteosarcoma Arising as a Secondary Malignancy following Treatment for Hematologic Cancer: A Report of 33 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS)

Stefan S Bielack iD, Vanessa Mettmann, Daniel Baumhoer, Claudia Blattmann, Birgit Burkhardt iD, Christoph K W Deinzer iD, Leo Kager iD, Matthias Kevric, Christine Mauz-Körholz iD, Peter Müller-Abt, Dirk Reinhardt iD, Alexandru-Anton Sabo iD und 4 weitere

Cancers · 11.05.2024 · 16 (10) · 1836

DOI: 10.3390/cancers16101836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 11.05.2024. Verfasst von Stefan S Bielack und 15 weiteren Autor:innen. Beteiligte Einrichtung: Klinikum Stuttgart-Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie 5 (Onkologie, Hämatologie, Immuno…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Förderkreis krebskranke Kinder Stuttgart e.V., Förderkreis krebskranke Kinder e. V. Stuttgart.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Osteosarcoma may arise as a secondary cancer following leukemias or lymphomas. We intended to increase the knowledge about such rare events. Patients and methods: We searched the Cooperative Osteosarcoma Study Group’s database for individuals who developed their osteosarcoma following a previous hematological malignancy. The presentation and treatment of both malignancies was investigated, and additional neoplasms were noted. Outcomes after osteosarcoma were analyzed and potential prognostic factors were searched for.

Results

A total of 33 eligible patients were identified (male: 23, female: 10; median age: 12.9 years at diagnosis of hematological cancer; 20 lymphomas, 13 leukemias). A cancer predisposition syndrome was evident in one patient only. The hematological cancers had been treated by radiotherapy in 28 (1 unknown) and chemotherapy in 26 cases, including bone-marrow transplantation in 9. The secondary bone sarcomas (high-grade central 27, periosteal 2, extra-osseous 2, undifferentiated pleomorphic sarcoma of bone 2) arose after a median lag-time of 9.4 years, when patients were a median of 19.1 years old. Tumors were considered radiation-related in 26 cases (1 unknown). Osteosarcoma-sites were in the extremities (19), trunk (12), or head and neck (2). Metastases at diagnosis affected eight patients. Information on osteosarcoma therapy was available for 31 cases. All of these received chemotherapy. Local therapy involved surgery in 27 patients, with a good response reported for 9/18 eligible patients. Local radiotherapy was given to three patients. The median follow-up was 3.9 (0.3–12.0) years after bone tumor diagnosis. During this period, 21 patients had developed events as defined, and 15 had died, resulting in 5-year event-free and overall survival rates of 40% (standard error: 9%) and 56% (10%), respectively. There were multiple instances of additional neoplasms. Several factors were found to be of prognostic value (p < 0.05) for event-free (osteosarcoma site in the extremities) or overall (achievement of a surgical osteosarcoma-remission, receiving chemotherapy for the hematologic malignancy) survival.

Conclusions

We were able to prove radiation therapy for hematological malignancies to be the predominant risk factor for later osteosarcomas. A resulting overrepresentation of axial and a tendency towards additional neoplasms affects prognosis. Still, selected patients may become long-term survivors with appropriate therapies, which is an argument against therapeutic negligence.

Schlagwörter

Stichwörter der Autor:innen

chemotherapyleukemialymphomaosteosarcomaprognosisradiation therapysecondary malignancy

Autor:innen und Institutionen

  • Klinikum Stuttgart-Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), 70174 Stuttgart, Germany.
  • Klinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und Onkologie, Universitätsklinikum Münster, 48149 Münster, Germany.
  • Knochentumor Referenzzentrum, Institut für Medizinische Genetik und Pathologie, Universitätsspital und Universität Basel, 4031 Basel, Switzerland.
  • Abteilung Innere Medizin VIII-Medizinische Onkologie und Pneumologie, Universitätsklinikum Tübingen, 72076 Tübingen, Germany.
  • St. Anna Kinderspital, Universitätsklinik für Kinder- und Jugendheilkunde der Medizinischen Universität Wien, 1090 Vienna, Austria.
  • St. Anna Children's Cancer Research Institute (CCRI), 1090 Vienna, Austria.

ORCID-Profile: Stefan S Bielack, Birgit Burkhardt, Christoph K W Deinzer, Leo Kager, Christine Mauz-Körholz, Dirk Reinhardt, Alexandru-Anton Sabo

Förderung

  • Förderkreis krebskranke Kinder Stuttgart e.V.
  • Förderkreis krebskranke Kinder e. V. Stuttgart

Zitieren

APA

Bielack, S. S., Mettmann, V., Baumhoer, D., Blattmann, C., Burkhardt, B., Deinzer, C. K. W., Kager, L., Kevric, M., Mauz-Körholz, C., Müller-Abt, P., Reinhardt, D., Sabo, A. A., Schrappe, M., Sorg, B., Windhager, R., & Hecker-Nolting, S. (2024). Osteosarcoma Arising as a Secondary Malignancy following Treatment for Hematologic Cancer: A Report of 33 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS). Cancers, 16(10), 1836. https://doi.org/10.3390/cancers16101836

Vancouver

Bielack SS, Mettmann V, Baumhoer D, Blattmann C, Burkhardt B, Deinzer CKW, et al. Osteosarcoma Arising as a Secondary Malignancy following Treatment for Hematologic Cancer: A Report of 33 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS). Cancers. 2024;16(10):1836. doi:10.3390/cancers16101836

BibTeX
@article{Bielack2024,
  author = {Bielack, Stefan S and Mettmann, Vanessa and Baumhoer, Daniel and Blattmann, Claudia and Burkhardt, Birgit and Deinzer, Christoph K W and Kager, Leo and Kevric, Matthias and Mauz-Körholz, Christine and Müller-Abt, Peter and Reinhardt, Dirk and Sabo, Alexandru-Anton and Schrappe, Martin and Sorg, Benjamin and Windhager, Reinhard and Hecker-Nolting, Stefanie},
  title = {Osteosarcoma Arising as a Secondary Malignancy following Treatment for Hematologic Cancer: A Report of 33 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS)},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {10},
  pages = {1836},
  doi = {10.3390/cancers16101836}
}
Kostenlos starten →